uestions, hopefully valuable questions, THE NEW YORKER, DECEMBER 12, 2011 31 HOUSE _OVERSIGHT_029926 --- PAGE BREAK --- could "cure" many ailments. Mesmer became highly sought after in Paris, where he would routinely "mesmerize" his followers-one of whom was Marie Antoinette. The King wasn't buying it,

claimed to have discovered a healing fluid that 7HE NEW YORKER. DECEMBER IP. 201 PI EFTA_R1_02046877 EFTA02695680 could "cure" many ailments. Mesmer became highly sought after in Paris, where he would routinely "mesmerize" his followers—one of whom was Marie Antoinette. The King wasn't buying

hese assets eon A they Olevanyde Zipped' C41/0e/ Boyne% The WC protean, and the 'apemen pretence do rot ironed again chin?, n the mew vat* of po t Mesmer, heeds as a roue of mato ricorrent. mon betruptcy °Thema) Mow Wormton a malt le uptn agues, You may obtan net Morreakin aloo fd the SPC Brodure b

Hindu divine energy of Shakti, the Hebraic ruach, the Cabalist’s Yesod, the Sufis Baraka, the Christian Holy Spirit, the Yogic breath energy, prana, Mesmer’s animal magnetism, Galvani’s life force, Goethe’s Gestaltung, Madam Blavatsky’s astral light, Georg Groddeck’s it, Henri Bergson’s elan vitale, Schr

eietho.G/.319:64:3I En su çaissicanart, moins Ut orpgra nearacer itoticenrel OS si Caria Sst reniai y lare° Ckeetterta Gal= an crins Wb= on danse Mesmer,' nesiote du *grec ace 51 alma ge> Pereire ei si tris cesurat nistateras Ya rs astre cee .ra eeKarenpy 4/0 • fle0 canons y ncee ap Jota acte zasar

es access to maraca rod annuity trains issued by aisle aimed thinpany encrare• companies Moat irriennc• nary ubsicluens cA uesFiNnval Sent Inc. — Mesmer, nuance, and annuity products — Not FDIC Hued • No bank guarantee. May lose yaks ▪ tmA tescene Management Account. Business Services Account BSA,

wring of ay signilkare change in pm financial situamn or ntestmert objectives. Foe each CONFIDENTIAL account MM, you choose one of The following Mesmer. objeclber • Produce CurtentOwome. lin-Aim es senng the generation et income any. • Mist* Opt*, Approciatan: Investments seeking growth of prncpa